Organisation paid for research Program year 2025 Source: CMS Open Payments

Amazon.Com, Inc.

Neither a doctor nor a teaching hospital

Research payments

$11,038

386 payments

Through program year 2025, Amazon.Com, Inc. is reported as receiving $11,038 in research payments, across 386 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$884	91
2024	Research	$4,733	208
2023	Research	$472	1
2022	Research	$4,949	86

Breakdown

Who paid Research payments · program years 2022–2025

Glaukos Corporation $11,038 386 payments

Studies the money was for Research payments · program years 2022–2025

A Phase 3, Multi-center, Randomized, Double-masked, Placebo/Sham-controlled Study to Evaluate the Safety and Efficacy of Oxygen Enriched, Non-invasive Epithelium-on Corneal Collagen Cross-linking in Eyes with Keratoconus $3,259 175 payments
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) $1,076 43 payments
A Prospective, Multicenter Study of the Glaukos Istent Infinite Trabecular Micro-Bypass System Model Is3 in Subjects With Mild to Moderate Primary Open-Angle Glaucoma $685 37 payments
A Dose Ranging, Multicenter, Sham-Controlled Study to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects with Keratoconus $472 1 payment
Multicenter, Randomized, Double-Masked, Active-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Travoprost Ophthalmic Topical Cream in Subjects with Open-angle Glaucoma or Ocular Hypertension $371 41 payments
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% $226 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.